SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

Share Price is delayed by 15 minutes
Get Live Data
4,670.00    220.00 (4.94%)
Bid:
4,620.00
Ask:
4,720.00
Spread: 100.00 (2.165%)
Market Cap: £311.05m
JDG Live PriceLast checked at - London Stock Exchange

Intraday Judges Scientific Share Chart

Directorate Change

23 May 2018 07:00

RNS Number : 9323O
Judges Scientific PLC
23 May 2018
 

Judges Scientific plc (the "Group", "Company" or "Judges")

Board changes

 

The Board of Judges Scientific, a group involved in the buy and build of scientific instrument businesses, announces the following board changes.

Charles Holroyd will join the Group as an Independent Non-Executive Director. Glynn Reece, Non-Executive Director, will be stepping down from the Board but will remain with the Group in the role of Company Secretary. The changes will take effect from 1 June 2018.

Charles has a BSc in Electrical and Electronics Engineering from Bristol University and an MBA from INSEAD and is a Chartered Engineer and a Fellow of the Institution of Engineering and Technology. Charles has held senior management positions within a number of publicly quoted companies. Most recently Charles worked at Oxford Instruments plc, which he joined in 1999 and where he served on the board from 2005 until 2013 and was responsible for group business development.

Following the above changes, the Board committees will comprise as follows:

Audit committee

Charles will join as a member of the audit committee. Following his appointment the audit committee comprise of three members being Ralph Elman, Ralph Cohen and Charles Holroyd with Ralph Elman acting as Chairman

Remuneration committee

Charles will join as a member of the remuneration committee. Following his appointment the remuneration committee will comprise of three members being Alex Hambro, Ralph Cohen and Charles Holroyd with Alex Hambro acting as Chairman

Commenting on the appointment, Alex Hambro, Chairman of Judges, said

"We are delighted to welcome Charles to the Group. Charles brings extensive knowledge of the scientific instrument sector in which we operate and we look forward to his guidance over the coming years as the Group continues to execute its buy and build growth strategy.

"On behalf of the Board, I would like to thank Glynn for his counsel and contribution to the Group as a Non-Executive Director and welcome his continued activity as our Company Secretary. Having been with the Group since its inception, he has worked with the Board to grow the business and deliver significantly value for our shareholders. His involvement has been hugely valued."

 

Regulatory Information

Charles John Arthur Holroyd, aged 62, currently holds, and has held (including all appointments during the five years preceding the date of this announcement), the following directorships and partnerships, other than of the Company:

Current Directorships

Phase Focus Limited

 

 

Past Directorships

HKL Technology A/S

Molecular Warehouse Limited 

Oxford Instruments Plc

Oxford Instruments Asylum Research Inc

Oxford Instruments Holdings Europe Limited

Oxford Instruments India Private Limited

Oxford Instruments Industrial Products Limited

Oxford Instruments Industrial Products Holdings Limited

Oxford Instruments Nanotechnology Tools Limited

Oxford Instruments Nordiska AB

Oxford Instruments Overseas Holdings Limited

Oxford Instruments Overseas Holdings 2008 Limited

Oxford Instruments Private Limited

Oxford Instruments SAS

Oxford Instruments Technology (Shanghai) Company Limited

Oxford Instruments UK 2013 Limited

Scienta Omicron

 

Charles Holroyd has confirmed that there is no other additional information to be disclosed under Schedule 2 (g) of the AIM Rules.

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses. The Group currently consists of 16 businesses acquired since it was re-admitted to AIM in 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queens' awards for innovation and export.

Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, dividends and through organic growth which the Group encourages by creating an environment for businesses to thrive in, with support and advice for entity management teams.

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

For further information, please visit www.judges.uk.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGUACAUPRGAP
Date   Source Headline
11th Jun 20264:34 pmRNSDirector/PDMR Shareholding
1st Jun 20262:24 pmRNSTotal Voting Rights
26th May 20265:18 pmRNSPurchase of Ordinary Shares
20th May 20262:52 pmRNSResult of AGM
11th May 20263:10 pmRNSDirector/PDMR Shareholding
8th May 20265:05 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSNotice of AGM
22nd Apr 202611:53 amRNSConfirmation of Full Year Results
9th Apr 202611:14 amRNSDirector/PDMR Shareholding
2nd Apr 20267:00 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSUnaudited Preliminary Results
25th Mar 20267:00 amRNSNotice of Investor Presentation
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Feb 20261:49 pmRNSDirector/PDMR Shareholding
2nd Feb 20269:38 amRNSTotal Voting Rights
29th Jan 20263:31 pmRNSDirector/PDMR Shareholding
29th Jan 20267:00 amRNSGrant of Options
22nd Jan 20267:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 202611:18 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSBlocklisting Return
22nd Dec 20257:00 amRNSBlocklisting Return
9th Dec 202510:25 amRNSDirector/PDMR Shareholding
3rd Dec 20257:00 amRNSAcquisition of the minority shareholding in GdB
26th Nov 20257:00 amRNSBoard Succession
13th Nov 20255:05 pmRNSDirector/PDMR Shareholding
11th Nov 202512:08 pmRNSDirector/PDMR Shareholding
3rd Nov 20257:00 amRNSTotal Voting Rights
20th Oct 20257:00 amRNSDirector/PDMR Shareholding
8th Oct 202511:43 amRNSDirector/PDMR Shareholding
1st Oct 202512:22 pmRNSTotal Voting Rights
18th Sep 20257:00 amRNSInterim Results
9th Sep 202511:42 amRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSNotice of Investor Presentation
6th Aug 20255:46 pmRNSDirector/PDMR Shareholding
1st Aug 20257:00 amRNSTotal Voting Rights
30th Jul 20257:00 amRNSDirector/PDMR Shareholding
25th Jul 202510:07 amRNSDirector/PDMR Shareholding
24th Jul 20254:06 pmRNSDirector/PDMR Shareholding
24th Jul 20257:00 amRNSHalf Year Trading Update
8th Jul 20253:53 pmRNSDirector/PDMR Shareholding
1st Jul 20255:08 pmRNSTotal Voting Rights
1st Jul 20257:00 amRNSAppointment of Group Acquisitions Executive
23rd Jun 20257:00 amRNSBlocklisting Return
9th Jun 20251:37 pmRNSDirector/PDMR Shareholding
4th Jun 20255:03 pmRNSPurchase of Ordinary Shares
30th May 202512:06 pmRNSTotal Voting Rights
23rd May 202511:25 amRNSResult of AGM
13th May 20255:18 pmRNSPurchase of Ordinary Shares
8th May 20255:27 pmRNSDirector/PDMR Shareholding
28th Apr 20257:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.